- Home
- ONB vs HALO Comparison
ONB vs HALO Comparison
Compare ONB & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ONB | HALO |
|---|---|---|
| Founded | 1834 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 7.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ONB | HALO |
|---|---|---|
| Price | $22.35 | $67.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $26.09 | ★ $73.33 |
| AVG Volume (30 Days) | ★ 2.8M | 2.2M |
| Earning Date | 01-20-2026 | 02-17-2026 |
| Dividend Yield | ★ 2.48% | N/A |
| EPS Growth | 2.73 | ★ 56.68 |
| EPS | 1.69 | ★ 4.74 |
| Revenue | ★ $2,110,915,000.00 | $1,242,852,000.00 |
| Revenue This Year | $45.61 | $34.83 |
| Revenue Next Year | $14.54 | $24.84 |
| P/E Ratio | ★ $13.35 | $14.29 |
| Revenue Growth | 20.70 | ★ 31.19 |
| 52 Week Low | $16.83 | $47.50 |
| 52 Week High | $24.49 | $79.50 |
Technical Indicators
Market Signals| Indicator | ONB | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 48.21 | 51.98 |
| Support Level | $22.95 | $67.95 |
| Resistance Level | $23.59 | $69.48 |
| Average True Range (ATR) | 0.34 | 1.59 |
| MACD | -0.13 | 0.47 |
| Stochastic Oscillator | 5.70 | 74.62 |
Price Performance
Historical ComparisonAbout ONB Old National Bancorp
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.